-
1.
公开(公告)号:US20170329227A1
公开(公告)日:2017-11-16
申请号:US15590422
申请日:2017-05-09
发明人: Masaki Ohashi , Ryosuke Taniguchi
CPC分类号: G03F7/0397 , C07C291/00 , C07C381/12 , C08K5/375 , C09D133/062 , G03F7/0045 , G03F7/0046 , G03F7/2002 , G03F7/2041 , H01L21/0274 , C08L33/062
摘要: A sulfonium compound having formula (1) exerts a satisfactory acid diffusion control function wherein R1, R2 and R3 are a C1-C20 monovalent hydrocarbon group which may contain a heteroatom, p=0-5, q=0-5, and r=0-4. A resist composition comprising the sulfonium compound is processed by lithography to form a resist pattern with improved resolution, LWR, MEF and CDU.
-
公开(公告)号:US08648058B2
公开(公告)日:2014-02-11
申请号:US13577797
申请日:2011-02-10
申请人: Amjad Ali , Michael Man-Chu Lo , Edward Metzger , Lin Yan
发明人: Amjad Ali , Michael Man-Chu Lo , Edward Metzger , Lin Yan
IPC分类号: A61K31/655 , C07C245/24
CPC分类号: C07C291/00 , C07C291/08 , C07C2601/08 , C07D249/04
摘要: A compound of formula I, wherein R1-R7 are defined herein, or stereoisomers therof, or pharmaceutically acceptable salts thereof, or pharmaceutically acceptable salts of stereoisomers thereof, and methods of using these compounds for treating hypertension.
摘要翻译: 式I化合物,其中R 1 -R 7在本文中定义,或其立体异构体,或其药学上可接受的盐,或其立体异构体的药学上可接受的盐,以及使用这些化合物治疗高血压的方法。
-
公开(公告)号:US11987551B2
公开(公告)日:2024-05-21
申请号:US17372383
申请日:2021-07-09
发明人: Bishwajit Nag , Ananda Sen , Nitish Nag , Arjun Sanyal , Srinivasan Narasimhan
IPC分类号: C07C69/618 , C07C219/28 , C07C251/86 , C07C257/08 , C07C291/00
CPC分类号: C07C69/618 , C07C219/28 , C07C251/86 , C07C257/08 , C07C291/00
摘要: Novel Styryl Carboxylate derivatives are provided which exhibit activity for the treatment of immunological diseases, inflammation, obesity, hyperlipidemia, hypertension, neurological diseases, and diabetes.
-
公开(公告)号:US20180066077A1
公开(公告)日:2018-03-08
申请号:US15558453
申请日:2016-06-17
申请人: LG Chem, Ltd.
发明人: Seung-Ho Choi , Min-Soo Kim , Cheol-Jae Kim , Zeong-Back Kim , Ji-Eun Kim , Won-Mun Choi , Dae-June Joe
CPC分类号: C08C19/25 , B60C1/0016 , C07C291/00 , C07F7/081 , C07F7/0834 , C07F7/1804 , C08C19/22 , C08C19/44 , C08F8/30 , C08F36/06 , C08F236/06 , C08F236/10 , C08K3/00 , C08K3/013 , C08K3/04 , C08K3/36 , C08L9/00 , C08L9/06 , C08L15/00 , C08F212/08 , C08L91/00 , C08L91/06 , C08K5/09 , C08K3/22 , C08K3/06
摘要: The present invention relates to a terminal modified and conjugated diene-based polymer rubber composition including a terminal modified and conjugated diene-based polymer which is characterized in that an aminosilane-based terminal modifier represented by Formula 1 or Formula 2 is combined at the terminal of a conjugated diene-based polymer, and a method for preparing the same.
-
公开(公告)号:US4460513A
公开(公告)日:1984-07-17
申请号:US436634
申请日:1982-10-25
申请人: G. David Mendenhall
发明人: G. David Mendenhall
IPC分类号: C07C203/00 , C07C77/00 , C07C77/02
CPC分类号: C07C291/00
摘要: Tertiary organic hyponitrite usable as initiators for polymerizing ethylenically unsaturated compounds are prepared by reacting an alkali metal, alkaline earth, ammonium or substituted ammonium salt of hyponitrite, such as sodium hyponitrite, with a tertiary organic halide, such as tert-butyl chloride, in the presence of one or more weak Friedel-Crafts catalysts, such as ferric or zinc chloride, and in a solution of a neutral solvent.
摘要翻译: 可用作聚合烯键式不饱和化合物的引发剂的三级有机次硝酸盐是通过将低亚硝酸盐如次亚硝酸钠的碱金属,碱土金属,铵或取代的铵盐与叔有机卤化物如叔丁基氯反应制备的 存在一种或多种弱的Friedel-Crafts催化剂,例如三价铁或氯化锌,以及在中性溶剂的溶液中。
-
公开(公告)号:US20240317670A1
公开(公告)日:2024-09-26
申请号:US18656402
申请日:2024-05-06
发明人: Bishwajit Nag , Ananda Sen , Nitish Nag , Arjun Sanyal , Srinivasan Narasimhan
IPC分类号: C07C69/618 , C07C219/28 , C07C251/86 , C07C257/08 , C07C291/00
CPC分类号: C07C69/618 , C07C219/28 , C07C251/86 , C07C257/08 , C07C291/00
摘要: Novel Styryl Carboxylate derivative compounds are provided which exhibit activity for the treatment of immunological diseases, inflammation, obesity, hyperlipidemia, hypertension, neurological diseases, and diabetes.
-
公开(公告)号:US09024069B2
公开(公告)日:2015-05-05
申请号:US14074829
申请日:2013-11-08
IPC分类号: A61K31/655 , C07C245/24 , C07D207/50 , C07C291/00
CPC分类号: C07D207/50 , A61K31/655 , C07C245/24 , C07C291/00
摘要: A compound of Formula (I): or a pharmaceutically acceptable salt of the compound. Also described are pharmaceutical formulations thereof and methods of using the same.
摘要翻译: 式(I)的化合物或该化合物的药学上可接受的盐。 还描述了其药物制剂及其使用方法。
-
公开(公告)号:US3530162A
公开(公告)日:1970-09-22
申请号:US3530162D
申请日:1968-07-19
申请人: DU PONT
发明人: FUCHS JULIUS J
IPC分类号: C07C255/24 , C07C291/00 , C07C121/42 , C07C121/46 , C07C121/66
CPC分类号: C07C255/00 , C07C291/00
-
公开(公告)号:US20240300883A1
公开(公告)日:2024-09-12
申请号:US18656138
申请日:2024-05-06
发明人: Bishwajit Nag , Ananda Sen , Nitish Nag , Arjun Sanyal , Srinivasan Narasimhan
IPC分类号: C07C69/618 , C07C219/28 , C07C251/86 , C07C257/08 , C07C291/00
CPC分类号: C07C69/618 , C07C219/28 , C07C251/86 , C07C257/08 , C07C291/00
摘要: Novel Dithiane derivative and methyl cinnamate compounds are provided which exhibit activity for the treatment of immunological diseases, inflammation, obesity, hyperlipidemia, hypertension, neurological diseases, and diabetes.
-
公开(公告)号:US20230272367A1
公开(公告)日:2023-08-31
申请号:US18316871
申请日:2023-05-12
发明人: Anuradha Bhattacharyya , Amal Dakka , Kerstin Effenberger , Vijayalakshmi Gabbeta , Wencheng Li , Nikolai Naryshkin , Christopher Trotta , Kari Wiedinger
IPC分类号: C12N15/10 , C07C255/00 , C07C291/00
CPC分类号: C12N15/10 , C12N15/102 , C07C255/00 , C07C291/00
摘要: In one aspect, described herein is an intronic recognition element for splicing modifier (iREMS) that can be recognized by a compound provided herein. In another aspect, described herein are methods for modulating the amount of a product of a gene, wherein a precursor RNA transcript transcribed from the gene contains an intronic REMS, and the methods utilizing a compound described herein. More particularly, described herein are methods for modulating the amount of an RNA transcript or protein product encoded by a gene, wherein a precursor RNA transcript transcribed from the gene comprises an intronic REMS, and the methods utilizing a compound described herein. In another aspect, provided herein are artificial gene constructs comprising an intronic REMS, and uses of those artificial gene constructs to modulate protein production. In another aspect, provided herein are methods for altering endogenous genes to comprise an intronic REMS, and the use of a compound described herein to modulate protein produced from such altered endogenous genes.
-
-
-
-
-
-
-
-
-